C, K., F, B., C, B., A, O., T, D., B, V., . . . Y, L. (2026). Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-71307-0
Chicago Style (17th ed.) CitationC, Kim, et al. "Real-world Evidence for Comparative Safety of Second-line Antihyperglycemic Agents in Older Adults with Type 2 Diabetes." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-71307-0.
MLA (9th ed.) CitationC, Kim, et al. "Real-world Evidence for Comparative Safety of Second-line Antihyperglycemic Agents in Older Adults with Type 2 Diabetes." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-71307-0.